MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuromodulatory propensity of Ginko biloba to offset rotenone induced behaviour and biochemical alteration

K. Rode, D. Khatri, M. Panchawadkar, P. Rane (Pune, India)

Meeting: 2018 International Congress

Abstract Number: 188

Keywords: Behavioral abnormalities, Neuroprotective agents, Rotenone

Session Information

Date: Saturday, October 6, 2018

Session Title: Neuropharmacology

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: The aim of present study was to evaluate neuromodulatory propensity of Gingko Biloba in rotenone induced Mice Model of Parkinson Disease in terms of improving behavioural and biochemical aspects.

Background: Gingko Biloba is an ancient Chinese tree which have substantial experimental evidence for its neuroprotective potential and their memory enhancement activity. Various reports on potential of Gingko Biloba apllication in neurological disorder has been evaluated in many in-vitro and in-vivo preclinical studies.

Methods: Animals were exposed to rotenone (1mg/kg) for a duration of three weeks showed remarkable diminished in behavioural paradigm (memory, learning and locomotor activity) oxidative protection (decreased activity of superoxide dismutase , catalase and reduced glutathione level , lipid peroxidation and nitrate estimation) and mitochondrial enzyme activity (complex-II succinate dehydrogenase (SDH), complex-III MTT (3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl-H-tetrazolium bromide) as compared to normal control group of mice.

Results: Oral administration of Gingko biloba at three different doses (50,100 and 200 mg/kg p.o.) were able to rescue animals significantly by improving behavior parameters ( P <0.001) oxidative damage (P<0.001) and mitochondrial enzyme complex activities (<0.05, P <0.01, P < 0.001) as compared to rotenone induced group (negative control). It is observed that extract of Gingko Biloba act as a neuromodulator by restoring motor deficits and increased the activities of antioxidant and mitochondrial enzymes activity.

Conclusions: The outcome of present study proves neuroprotective role of Gingko Biloba against rotenone induced Parkinson’s in mice and offers a strong explanation for the therapeutic prospective of Gingko biloba in the management of PD .

References: Patricia R. et al., 2012 Effect of a phytopharmaceutical medicine , Ginko biloba extract 761, in an animal model of Parkinson’s disease: Therapeutic perspectives Nutrition journal 28 1081-1088. Lingling H. et al., 2015 Lithium protects dopaminergic cells from Rotenone toxicity via autophagy enhancement BMS Neuroscience 16:82.

To cite this abstract in AMA style:

K. Rode, D. Khatri, M. Panchawadkar, P. Rane. Neuromodulatory propensity of Ginko biloba to offset rotenone induced behaviour and biochemical alteration [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/neuromodulatory-propensity-of-ginko-biloba-to-offset-rotenone-induced-behaviour-and-biochemical-alteration/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuromodulatory-propensity-of-ginko-biloba-to-offset-rotenone-induced-behaviour-and-biochemical-alteration/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley